TABLE 3

Yield of In-Hospital Neurological Management of Patients With an ALTE

n (%)Sensitivity, % (95% CI)Specificity, % (95% CI)PPV, % (95% CI)NPV, % (95% CI)
Neurology consult obtained137 (29)71.0 (44.0–90.0)73.0 (68.0–77.0)8.8 (4.6–15.0)99.0 (96.0–100.0)
Neurology consult positive52 (11)42.0 (15.0–72.0)62.0 (53.0–71.0)9.6 (3.2–21.0)92.0 (84.0–97.0)
EEG abnormal (N = 156)615.0 (2.0–45.0)97.0 (93.0–99.0)33.0 (4.3–77.0)93.0 (87.0–96.0)
CNS imaging abnormal (N = 199)56.7 (0.2–32.0)98.0 (95.0–100.0)25.0 (0.6–81.0)93.0 (88.0–96.0)
Antiepileptic drug prescribed23 (4.9)30.0 (10.0–56.0)96.0 (94.0–98.0)22.0 (7.5–44.0)9.07 (95.0–99.0)
  • Sensitivity, specificity, and PPVs and NPVs for patients in the ALTE cohort who went on to develop chronic epilepsy (n = 17). "Neurology consult positive" was for the outcome of chronic epilepsy and was positive if an antiepileptic drug was prescribed and/or follow-up was arranged in pediatric neurology clinic.